Back to companies

Sorrento Therapeutics Inc: Overview

Sorrento Therapeutics Inc (Sorrento) is a biopharmaceutical company that focuses on developing therapeutics for the treatment of cancer, osteoarthritis and autoimmune diseases. The company’s immunotherapy pipeline portfolio consists of a CD38 CAR-T, CD38 ADC, CD38 DAR-T and Sephrehvir for the treatment of cancer. Sorrento is also investigating COVID19 programs which include Coviguard, Covidrops and Covishield, among others for the treatment of COVID-19. Its marketed products include ZTlido, a lidocaine topical system for the treatment of postherpetic neuralgia (PHN). The company works in collaboration with biopharmaceutical companies and academic institutions to develop novel immunotherapies. Sorrento is headquartered in San Diego, California, the US.

Headquarters United States of America

Address 4955 Directors Place, San Diego, California, 92121


Telephone 1 858 2034100

No of Employees 799

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange SRNE (NASD)

Revenue (2020) $52.9M 32.3% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX -43.5% (2020 vs 2019)

Market Cap* $710.9M

Net Profit Margin (2020) XXX -8.5% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Sorrento Therapeutics Inc

140+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Sorrento Therapeutics Inc’s relevant decision makers and contact details.

140+

Pipeline Drugs

Identify which of Sorrento Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

130+

Clinical Trials

Determine Sorrento Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

120+

Catalyst Calendar

Proactively evaluate Sorrento Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

16+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

13+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Marketed Drugs

Understand Sorrento Therapeutics Inc’s commercialized product portfolio to stay one step ahead of the market.

1

Sales & Consensus Forecasts

Understand the current and future drug revenue for Sorrento Therapeutics Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

40+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

14+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

9

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

2

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Sorrento Therapeutics Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Marketed: ZTlido - Postherpetic neuralgia (PHN), ZTlido
Pipeline: COVITRACE
COVID1-19: COVISTIX
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Others In August, the company announced the completion of the SAD portion of the Phase 1 study of its oral main viral protease inhibitor, the STI-1558.
2022 Contracts/Agreements In August, Scilex Holding Company entered into a product distribution agreement with CH Trading Group to distribute Scilex’s lead non-opioid commercial pain management product, ZTlido.
2022 Regulatory Approval In July, the company announced the FDA clearance of a Phase 1 study of its oral main viral protease (Mpro) inhibitor, STI-1558, in patients with impaired renal and hepatic function.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Sorrento Therapeutics Inc BioNTech SE Exelixis Inc Atara Biotherapeutics Inc Adaptimmune Therapeutics Plc
Headquarters United States of America Germany United States of America United States of America United Kingdom
City San Diego Mainz Alameda South San Francisco Abingdon
State/Province California - California California -
No. of Employees 799 1,179 954 434 494
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Henry Ji, Ph.D. President; Chief Executive Officer; Chairman Executive Board 2017 57
Elizabeth Czerepak Chief Business Officer; Chief Financial Officer; Executive Vice President; Director Executive Board 2022 -
Mike Royal, M.D. Chief Medical Officer Senior Management - -
Brain Cooley Senior Vice President - Corporate Communications and Investor Relations Senior Management - -
Bill Farley Vice President - Business Development Senior Management - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer